IBO Stock: Price, Forecast, Financials & AI Analysis

High

Open

VWAP

Vol

Mkt Cap

Low

Amount

EV/EBITDA(TTM)

Total Shares

EV/OCF(TTM)

P/S(TTM)

Valuation Metrics

The current forward P/E ratio for Impact Biomedical Inc (IBO.A) is 0.00, compared to its 5-year average forward P/E of 0.00. For a more detailed relative valuation and DCF analysis to assess Impact Biomedical Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

0.00

Current PE

0.00

Overvalued PE

0.00

Undervalued PE

0.00

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

0.00

Current EV/EBITDA

0.00

Overvalued EV/EBITDA

0.00

Undervalued EV/EBITDA

0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

N/A

5Y Average PS

0.00

Current PS

0.00

Overvalued PS

0.00

Undervalued PS

0.00

Financials

Annual

Quarterly

N/A

Total Revenue

N/A

Operating Profit

N/A

Net Income after Tax

N/A

EPS - Diluted

N/A

Free Cash Flow

N/A

Gross Profit Margin - %

N/A

FCF Margin - %

N/A

Net Margin - %

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Hedge Fund

Hedge Funds are Neutral. There are no significant trading trends over the last quarter.

Sold

Bought

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

IBO News & Events

Events Timeline

No data

News

8.5

2025-12-23Benzinga

ZIM Integrated Shipping Shares Surge 7.6% on Acquisition Proposals

9.0

2025-08-18Newsfilter

Impact Biomedical Inc (IBO) Announces Issuance of US Patent for 3F™

9.5

2025-06-25Benzinga

Why BlackBerry Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket

People Also Watch

Frequently Asked Questions

What is Impact Biomedical Inc (IBO) stock price today?

The current price of IBO is 0.505 USD — it has decreased -0.2 % in the last trading day.

What is Impact Biomedical Inc (IBO)'s business?

Impact Biomedical, Inc. is a biotechnology company engaged in discovering, developing, and patenting healthcare solutions. It discovers, confirms, and patents science and technologies, which can be developed into new offerings in biopharmaceuticals and consumer healthcare and wellness in collaboration with external partners through research, licensing, co-development, joint ventures, and other relationships. It has several technologies that are in continuing development, which include Linebacker, Laetose, Functional Fragrance Formulation (3F), Equivir/Equivir G, and Celios. Linebacker is a platform of small molecule electrophilically enhanced polyphenol compounds with potential application in oncology (solid tumors), inflammatory disorders, and neurology. Laetose technology is derived from a combination of multiple sugars independently with myo-inositol. 3F is a suite of organic functional fragrances. Celios is an air purification technology. It also evaluates additional technologies.

What is the price predicton of IBO Stock?

Wall Street analysts forecast IBO stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for IBO is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Impact Biomedical Inc (IBO)'s revenue for the last quarter?

Impact Biomedical Inc revenue for the last quarter amounts to 18.00K USD, decreased % YoY.

What is Impact Biomedical Inc (IBO)'s earnings per share (EPS) for the last quarter?

Impact Biomedical Inc. EPS for the last quarter amounts to -0.12 USD, decreased -300.00 % YoY.

What changes have occurred in the market's expectations for Impact Biomedical Inc (IBO)'s fundamentals?

The market is revising No Change the revenue expectations for IBO for , with the revenue forecasts being adjusted by % over the past three months. During the same period, the stock price has changed by -18.01%.

How many employees does Impact Biomedical Inc (IBO). have?

Impact Biomedical Inc (IBO) has 2 emplpoyees as of January 10 2026.

What is Impact Biomedical Inc (IBO) market cap?

Today IBO has the market capitalization of 52.83M USD.